| Identification | More | [Name]
5-Bromonicotinic acid | [CAS]
20826-04-4 | [Synonyms]
3-BROMO-5-PYRIDINE CARBOXYLIC ACID
3-BROMO PYRIDINE-5-CARBOXYLIC ACID
3-PYRIDINECARBOXYLIC ACID, 5-BROMO-
5-BROMO-3-PYRIDINECARBOXYLIC ACID
5-BROMONICOTINC ACID
5-BROMONICOTINIC ACID
5-BROMOPYRIDINE-3-CARBOXYLIC ACID
AKOS BBS-00007710
AURORA KA-3027
IFLAB-BB F3095-3197
RARECHEM AL BO 0841
TIMTEC-BB SBB003524
5-bromo-3-pyridinecarboxylicaci
5-bromo-nicotinicaci
5-BromonicotinicAcid98%
5-Bromo-3-pyridinecarboxylic
5-Bromonicotic acid
5-BROMOPYRIDINE-3-CARBOXYLIC ACID/5-BROMONICOTINIC ACID
5-BROMO NICOTINIC ACID 5-BROMO NICOTINIC ACID
5-Bromonicotinic acid, 5-Bromopyridine-3-carboxylic acid | [EINECS(EC#)]
244-065-5 | [Molecular Formula]
C6H4BrNO2 | [MDL Number]
MFCD00009783 | [Molecular Weight]
202.01 | [MOL File]
20826-04-4.mol |
| Chemical Properties | Back Directory | [Appearance]
Light yellow Cryst | [Melting point ]
178-180 °C(lit.)
| [Boiling point ]
259.67°C (rough estimate) | [density ]
1.7477 (rough estimate) | [vapor pressure ]
0.01Pa at 25℃ | [refractive index ]
1.6120 (estimate) | [storage temp. ]
2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Powder | [pka]
3.08±0.10(Predicted) | [color ]
White to yellow-gray or light brown | [Detection Methods]
HPLC,NMR | [BRN ]
115854 | [InChI]
InChI=1S/C6H4BrNO2/c7-5-1-4(6(9)10)2-8-3-5/h1-3H,(H,9,10) | [InChIKey]
FQIUCPGDKPXSLL-UHFFFAOYSA-N | [SMILES]
C1=NC=C(Br)C=C1C(O)=O | [LogP]
1.17-1.29 at 23.5℃ and pH6.4 | [CAS DataBase Reference]
20826-04-4(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [RTECS ]
QT0868000
| [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [HS Code ]
29333999 |
| Raw materials And Preparation Products | Back Directory | [Raw materials]
3-Bromo-5-methylpyridine-->Methyl 5-bromonicotinate-->10-methoxy-1,6-dimethylergoline-8beta-methanol-->DIMETHYL 5-BROMOPYRIDINE-2,3-DICARBOXYLATE-->5-Bromonicotinamide-->2,4'-Dibromoacetophenone-->NICOTINYL CHLORIDE HYDROCHLORIDE-->3-Bromoquinoline-->3,5-Dibromopyridine | [Preparation Products]
5-Aminonicotinic acid-->5-Fluoronicotinic acid-->5-AMINO-NICOTINIC ACID METHYL ESTER-->2-(5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)propan-2-ol-->(5-BROMO-PYRIDIN-3-YL)-ACETONITRILE-->3-BroMo-5-(prop-1-en-2-yl)pyridine-->3-Bromo-5-(Chloromethyl)Pyridine Hydrochloride-->3-Bromo-1,5-naphthyridine-->3-Amino-5-bromopyridine |
| Hazard Information | Back Directory | [Chemical Properties]
Light yellow Cryst | [Uses]
5-Bromopyridine-3-carboxylic acid (5-bromonicotinic acid) was used in the synthesis of 3-guanidinomethyl-5-iodopyridine. | [Reactions]
5-Bromonicotinic acid could used as starting material to synthesize 3-guanidinomethyl-5-iodopyridine. It is also used to prepare four novel multifunctional coordination compounds with different lanthanide(III) ions (Dy, Tb, Yb, and Nd). These materials possess different structures and dimensionalities and show interesting magnetic and luminescence properties, as well as a complete absence of cytotoxicity both in cancer and non-cancer Caco-2 cells[1-2].
| [Synthesis Reference(s)]
Journal of the American Chemical Society, 70, p. 2381, 1948 DOI: 10.1021/ja01187a020 | [Purification Methods]
The acid is recrystallised from H2O and then from EtOH using charcoal. The amide has m 219-219.5o (from aqueous EtOH), and the methyl ester, prepared by addition of ethereal diazomethane, can be purified by sublimation in a vacuum and has m 98-99o. The acid chloride also can be sublimed in vacuo and has m 74-75o and gives the methyl ester in MeOH. [Graf J Prakt Chem 138 244 1933, Bachman & Micucci J Am Chem Soc 70 2381 1948, Garcia et al. J Am Chem Soc 82 4430 1960, Misic-Vokovic et al. J Chem Soc 34 1978, Beilstein 22/2 V 181.] | [References]
[1] Vaidyanathan G, et al. Iodopyridine-for-iodobenzene substitution for use with low molecular weight radiopharmaceuticals: application to m-iodobenzylguanidine. Bioconjugate Chemistry, 1998; 9: 758–764.
[2] Ruiz C, et al. Multifunctional coordination compounds based on lanthanide ions and 5-bromonicotinic acid: magnetic, luminescence and anti-cancer properties. CrystEngComm, 2019; 21: 3881-3890. |
|
|